R4 Draft for Comment
Clinical SummaryThis page is part of the FHIR Specification (v3.2.0: R4 Ballot 1). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B R4 R3 R2
| (No assigned work group) | Maturity Level: N/A | Ballot Status: Informative |
| Extensions: | |
| openEHR-test | test : Observations that confirm or refute the risk and/or the substance. |
| openEHR-location | location : The anatomical location / body site(s) where the symptoms manifested. |
| openEHR-exposureDate | exposureDate : Record of the date and/or time of the first exposure to the Substance for this Reaction Event. |
| openEHR-exposureDuration | exposureDuration : The amount of time the individual was exposed to the Substance. |
| openEHR-exposureDescription | exposureDescription : Text description about exposure to the Substance. |
| openEHR-administration | administration : Link to an actual medication administration record with the full details of the administration, if a link is known. |
| openEHR-management | management : Text description about the clinical management provided. |
| openEHR-careplan | careplan : Additional details about the clinical management provided for this Reaction Event. |
®© HL7.org 2011+. FHIR Release 4 Draft for Comment (Jan-2018 v3.2.0-12885) generated on Wed, Dec 20, 2017 15:56+1100. QA Page
Links: Search |
Version History |
Table of Contents |
Credits |
Compare to DSTU3 |
|
Propose a change